BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21175722)

  • 1. Atypical fibrous histiocytoma with aberrant cytokeratin-5/6 expression.
    Cassarino DS
    J Cutan Pathol; 2011 Feb; 38(2):179-82. PubMed ID: 21175722
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: CD117 immunoreactivity in atypical fibroxanthoma.
    Barr KL; Russo JJ; Vincek V
    Am J Dermatopathol; 2009 Feb; 31(1):96-8. PubMed ID: 19155737
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosquamous carcinoma: a report of nine cases with p63 and cytokeratin 5/6 staining.
    Ko CJ; Leffell DJ; McNiff JM
    J Cutan Pathol; 2009 Apr; 36(4):448-52. PubMed ID: 19278431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMB-45 expression in a clear cell variant of atypical fibroxanthoma.
    Cai JP; Randall B
    J Cutan Pathol; 2006 Feb; 33(2):186-8. PubMed ID: 16420318
    [No Abstract]   [Full Text] [Related]  

  • 5. CD117 immunoreactivity in atypical fibroxanthoma.
    Mathew RA; Schlauder SM; Calder KB; Morgan MB
    Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palisading subcutaneous fibrous histiocytoma.
    Fukunaga M
    Pathol Int; 2004 May; 54(5):360-3. PubMed ID: 15086842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD117 is not a useful marker for diagnosing atypical fibroxanthoma.
    Barr KL; Russo JJ; Vincek V
    Am J Dermatopathol; 2010 Jul; 32(5):528. PubMed ID: 20526172
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN; Cooke ER; Florentino F; Sheehan DJ
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of monocytic and dendritic cell markers in benign cutaneous fibrous histiocytoma (dermatofibroma).
    Nonaka D
    Histopathology; 2008 Jun; 52(7):896-7. PubMed ID: 18462367
    [No Abstract]   [Full Text] [Related]  

  • 10. CD117 in atypical fibroxanthoma: tumor or stroma?
    Beer TW
    Am J Dermatopathol; 2008 Aug; 30(4):401-2. PubMed ID: 18645317
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.
    Kemmerling R; Dietze O; Müller S; Neureiter D
    Pathol Res Pract; 2009; 205(5):365-70. PubMed ID: 19155147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell atypical fibroxanthoma - report of a case with review of the literature.
    Murali R; Palfreeman S
    J Cutan Pathol; 2006 May; 33(5):343-8. PubMed ID: 16640540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rare benign mesenchymal tumors of the skin and subcutaneous tissue with atypical bizarre giant cells (pleomorphic lipoma, giant cell fibroblastoma, atypical "pseudosarcomatous" cutaneous fibrous histiocytoma].
    Katenkamp D; Kosmehl H
    Pathologe; 1990 Sep; 11(5):275-82. PubMed ID: 2175894
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A; Stańczyk J; Woyke S
    Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
    Rizzardi C; Angiero F; Melato M
    Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granular cell atypical fibroxanthoma: case report and review of the literature.
    Wright NA; Thomas CG; Calame A; Cockerell CJ
    J Cutan Pathol; 2010 Mar; 37(3):380-5. PubMed ID: 19341433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical dermatofibroma with predominant epithelioid/deciduoid-like cell component. Histogenetic considerations in the wide spectrum of fibrohistiocytic dermal tumours.
    Amico P; Vecchio GM; Bisceglia M; Vasquez E; Magro G
    Pathologica; 2010 Jun; 102(3):115-8. PubMed ID: 21171517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 5/6 expression in benign and malignant breast lesions.
    Bhalla A; Manjari M; Kahlon SK; Kumar P; Kalra N
    Indian J Pathol Microbiol; 2010; 53(4):676-80. PubMed ID: 21045391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts.
    Kideryová L; Lacina L; Dvoránková B; Stork J; Cada Z; Szabo P; André S; Kaltner H; Gabius HJ; Smetana K
    J Dermatol Sci; 2009 Jul; 55(1):18-26. PubMed ID: 19414239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.